| Advanced and Metastatic Breast Cancer |
1 |
1 |
| Head and Neck Cancer |
0 |
0.9 |
| Breast Cancer |
0 |
0.92 |
| Brain Metastasis |
0 |
0.99 |
| Metastasis |
0 |
0.73 |
| Biologic Therapy |
0 |
0.71 |
| Brain |
0 |
0.53 |
| HER2-Positive Breast Cancer |
0 |
0.98 |
| Antineoplastic Drug |
0 |
0.42 |
| Cancer |
0 |
0.37 |
| Breast |
0 |
0.34 |
| Targeted Cancer Therapy |
0 |
0.29 |
| Humanized Monoclonal Antibody |
0 |
0.15 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Hodgkin Lymphoma |
0 |
0.07 |
| Antibody Drug Conjugates |
0 |
0.06 |
| Board Certification |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| HER2 Inhibitor |
0 |
0.06 |
| Prognosis |
0 |
0.06 |